| Dr John Li, MD | |
|
1100 Tunnel Road, Asheville, NC 28805-2087 | |
| (828) 298-7911 | |
| (828) 299-2567 |
| Full Name | Dr John Li |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 32 Years |
| Location | 1100 Tunnel Road, Asheville, North Carolina |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245296227 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 200001195 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Rockingham Health Care Inc | 6800157181 | 21 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
The measure, introduced by Rep. Mike Rogers, R-Mich., would allow consumers the same exemption process being exercised by some employers and unions. Meanwhile, House Oversight Committee Chairman Darrell Issa, R-Calif., has raised questions about waivers granted to "mini-med" plans.
› Verified 7 days ago
| Entity Name | Morehead Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194153569 PECOS PAC ID: 6204806342 Enrollment ID: O20040727001498 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
The measure, introduced by Rep. Mike Rogers, R-Mich., would allow consumers the same exemption process being exercised by some employers and unions. Meanwhile, House Oversight Committee Chairman Darrell Issa, R-Calif., has raised questions about waivers granted to "mini-med" plans.
› Verified 7 days ago
| Entity Name | Dlp Western Carolina Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609281641 PECOS PAC ID: 9032338975 Enrollment ID: O20140908002531 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
The measure, introduced by Rep. Mike Rogers, R-Mich., would allow consumers the same exemption process being exercised by some employers and unions. Meanwhile, House Oversight Committee Chairman Darrell Issa, R-Calif., has raised questions about waivers granted to "mini-med" plans.
› Verified 7 days ago
| Entity Name | Unc Rockingham Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538664099 PECOS PAC ID: 6800157181 Enrollment ID: O20180605000262 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
The measure, introduced by Rep. Mike Rogers, R-Mich., would allow consumers the same exemption process being exercised by some employers and unions. Meanwhile, House Oversight Committee Chairman Darrell Issa, R-Calif., has raised questions about waivers granted to "mini-med" plans.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Li, MD 1100 Tunnel Road, Surgery (112), Asheville, NC 28805-2087 Ph: (828) 299-2540 | Dr John Li, MD 1100 Tunnel Road, Asheville, NC 28805-2087 Ph: (828) 298-7911 |
News Archive
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
A 25-year follow-up study of a comprehensive early health and education intervention program begun in the early 1970s shows that inner-city children who participated not only did better educationally, but had better physical and mental health in adulthood.
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
The measure, introduced by Rep. Mike Rogers, R-Mich., would allow consumers the same exemption process being exercised by some employers and unions. Meanwhile, House Oversight Committee Chairman Darrell Issa, R-Calif., has raised questions about waivers granted to "mini-med" plans.
› Verified 7 days ago
William Alan Bradshaw, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 14 Medical Park Dr, Asheville, NC 28803 Phone: 828-252-3366 Fax: 828-258-0891 | |
Darren P Bryant, MD Surgery Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Suite 4200, Asheville, NC 28801 Phone: 828-213-1995 | |
John P Henretta, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 Asheland Ave, Asheville, NC 28801 Phone: 828-213-9090 Fax: 828-213-9091 | |
William Shillinglaw, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1995 Fax: 828-213-1992 | |
Dr. Emma Goldsmith Rooney, MD Surgery Medicare: Medicare Enrolled Practice Location: 222 Asheland Ave, Asheville, NC 28801 Phone: 828-213-9090 | |
Michael J Schurr, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Suite 4200, Asheville, NC 28801 Phone: 828-213-1994 | |
Dr. Amir Ali Neshat, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 28 Ashley Rd, Asheville, NC 28805 Phone: 828-298-2014 |